Kawakami Y, Ito M, Hirayama M, Sahashi K, Ohkawara B, Masuda A, et al
BPC-157s effects on multiple neurotransmitter systems create theoretical interaction points with psychiatric medications, yet interactions are not well studied. Particular concerns include serotonin syndrome risk when combined with SSRIs (since BPC-157 modulates serotonin in complex regional patterns), unpredictable effects on dopaminergic medications (antipsychotics, ADHD treatments, Parkinsons medications), and unknown interactions with benzodiazepines despite the animal studies showing tolerance prevention
Combination potential: stacking and synergy One of the most important differences between cagrilintide and retatrutide is their potential for combination therapy
Pharmacology Biochemistry and Behavior, 77 (2), 399-404
Duvyzats approval follows that of Sareptas Elevidys, which got the FDAs green light in June 2023, and Santhera Pharmaceuticals Agamree, which was approved in October
It is not an autologous fat transfer that uses liposuction to harvest fat from one area of your own body and inject it into another